These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14210646)

  • 21. [MYOCARDIAL METABOLISM. SOME PRESENT-DAY PRACTICAL EVENTS].
    LABADIE P
    Rev Prat; 1964 Feb; 14():683-90. PubMed ID: 14141294
    [No Abstract]   [Full Text] [Related]  

  • 22. [A new group of competitive divalent Ca-antagonists (iproveratril, D 600, prenylamine) with potent inhibitory effects on electromechanical coupling in mammalian myocardium].
    Fleckenstein A; Tritthart H; Flackenstein B; Herbst A; Grün G
    Pflugers Arch; 1969; 307(2):R25. PubMed ID: 5814829
    [No Abstract]   [Full Text] [Related]  

  • 23. [Control of myocardial metabolism by verapamil. Sites of action and therapeutic effects].
    Fleckenstein A
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1317+. PubMed ID: 5536556
    [No Abstract]   [Full Text] [Related]  

  • 24. [VISNADINE IN THE TREATMENT OF MYOCARDIAL INFARCT AND CORONARY DISEASE].
    TETREAU H
    Prog Med (Paris); 1964 Jul; 92():485-94. PubMed ID: 14182038
    [No Abstract]   [Full Text] [Related]  

  • 25. [Parallel influence of isometric tension development and O2 consumption of isolated papillary muscles under the influence of Ca ions, adrenaline, isoproteranol and organic Ca antagonists (iproveratril, D 600, prenylamine)].
    Byon KY; Fleckenstein A
    Pflugers Arch; 1969; 312(1):R8-9. PubMed ID: 5390309
    [No Abstract]   [Full Text] [Related]  

  • 26. [The antiarrhythmic and coronary-dilating properties of verapamil in patients ith ischemic heart disease].
    Votcal BE; Lozinskij LG; Goldberg VA; Venediktova MG; Gribova OA
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1281+. PubMed ID: 5312386
    [No Abstract]   [Full Text] [Related]  

  • 27. ON SUDDEN DEATH.
    PRUITT RD
    Am Heart J; 1964 Jul; 68():111-8. PubMed ID: 14192339
    [No Abstract]   [Full Text] [Related]  

  • 28. [EXPERIENCES WITH THE NEW CORONARY VASODILATOR SYNADRIN. CLINICAL CONTROL AND ELECTROCARDIOGRAPHY OF THE TREATED CASES].
    BERJILLOSCORDON M; BELLIDOGAMEZ JA; PELAEZGOMEZ A
    Rev Clin Esp; 1964 Jul; 94():24-41. PubMed ID: 14179918
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical assessment of certain preparations used in coronary insufficiency].
    Votchal BE; Gol'dberg VA
    Klin Med (Mosk); 1970 Feb; 48(2):48-53. PubMed ID: 5425982
    [No Abstract]   [Full Text] [Related]  

  • 30. [OBSERVATIONS ON THERAPY OF CORONARY DISEASE WITH PHENYLPROPYLDIPHENYLPROPYLAMINE].
    ZANETTIN G
    Gazz Int Med Chir; 1964 Apr; 68():690-7. PubMed ID: 14145735
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cardiac arrhythmias in myocardial infarct].
    Lüderitz B; d'Alnoncourt CN
    Internist (Berl); 1980 Nov; 21(11):652-61. PubMed ID: 7005159
    [No Abstract]   [Full Text] [Related]  

  • 32. [ISOPTIN (D-365), CLINICAL STUDIES ON THE TREATMENT OF CORONARY HEART DISEASE].
    STRAESSLE B; BURCKHARDT D
    Schweiz Med Wochenschr; 1965 May; 95():667-72. PubMed ID: 14305765
    [No Abstract]   [Full Text] [Related]  

  • 33. [CATECHOLAMINE EXCRETION AND THE CLINICAL PICTURE IN THE MANAGEMENT OF CARDIAC INFARCTION AND CORONARY INSUFFICIENCY WITH N 3-PHENYLPROPYL -(2) 1, 1-DIPHENYL-PROPYL-(3)-AMINE].
    GAWELLEK F; ECKERT H
    Dtsch Gesundheitsw; 1964 Jul; 19():1339-46. PubMed ID: 14243103
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of Verapamil on the metabolism of myocardium].
    Haas H; Gokel M
    Arzneimittelforschung; 1970 May; 20(5):647-55. PubMed ID: 4393245
    [No Abstract]   [Full Text] [Related]  

  • 35. An overall review on prenylamine mechanisms of action in experimental models of myocardial damage.
    Milei J; Vazquez A; Bolomo NJ
    Cardiology; 1982; 69(4):192-202. PubMed ID: 6293707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A-V conduction in coronary disease and in myocardial infarct].
    CANIGGIA A
    Folia Cardiol; 1950 Apr; 9(2):107-33. PubMed ID: 24538646
    [No Abstract]   [Full Text] [Related]  

  • 37. [Objective evaluation of the therapeutic activity of iproveratril].
    Cherchi A; Raffo M; Bina M; Fonzo R; Maxia G; Esu MP
    Minerva Cardioangiol; 1971 Mar; 19(3):123-32. PubMed ID: 5553461
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prenylamine in the therapy of coronary disease].
    Villani M
    Minerva Med; 1973 Mar; 64(20):1020-2. PubMed ID: 4704729
    [No Abstract]   [Full Text] [Related]  

  • 39. [Metabolic effects of various palliative drugs for coronary insufficiency].
    Deltour G
    Therapie; 1970; 25(2):293-322. PubMed ID: 4404034
    [No Abstract]   [Full Text] [Related]  

  • 40. [DRUG THERAPY OF CORONARY INSUFFICIENCY].
    FISCHER K
    Med Klin; 1965 May; 60():847-51. PubMed ID: 14307641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.